enhancement of infectivity of a non-syncytium inducing hiv-1 by scd4 and by human antibodies that neutralize syncytium inducing hiv-1.

NLM AIDSLINE Enhancement of infectivity of a non-syncytium inducing HIV-1 by sCD4 and by human antibodies that neutralize syncytium inducing HIV-1. Schutten M; Andeweg AC; Bosch ML; Osterhaus AD; Erasmus University
April 30, 1995

Scand J Immunol. 1995 Jan;41(1):18-22. Unique Identifier : AIDSLINE Enhancement of virus infectivity after sCD4 treatment has been documented for SIVagm and HIV-2. It has been suggested that a similar phenomenon may play a role in HIV-1 infection. In the present study we have analysed biological activities of virus neutralizing polyclonal and monoclonal human antibodies and of sCD4, towards HIV-1 chimeras with envelope proteins derived from one donor, which display different biological phenotypes. The antibodies, which recognize the V3 and/or the CD4 binding domains of the glycoproteins of these viruses and also sCD4 showed different levels of virus neutralizing activity toward the syncytium inducing HIV-1 strains. In contrast, they all dramatically enhanced the infectivity of an HIV-1 chimera with an envelope glycoprotein displaying the non-syncytium-inducing phenotype. Given the relatively conserved nature of non-syncytium-inducing HIV-1 surface glycoproteins early after infection, these data suggest a major role for antibody mediated enhancement of virus infectivity in the early pathogenesis of HIV-1 infection. Antibodies, Monoclonal/IMMUNOLOGY Antibody Affinity Antigens, CD4/METABOLISM Cell Fusion Gene Products, env/IMMUNOLOGY Human HIV Antibodies/IMMUNOLOGY HIV-1/IMMUNOLOGY/*PATHOGENICITY In Vitro Neutralization Tests Support, Non-U.S. Gov't JOURNAL ARTICLE

Most Read: Latest Added Related Topics White House LGBT Conference on HIV/AIDS UNITED STATES: White House in Atlanta: LGBT AIDS Conference No more single-theme conferences: global HIV prevention conference planned FHI 360 Senior Scientist Lut Van Damme Receives International Microbicide Conference Lifetime Achievement Award Equatorial Guinea Ministry of Health and Social Welfare and UNICEF Refute Erroneous AIDS Prevalence Figures Photographs from A Day with HIV Now Online Bulgaria urges Libya to investigate AIDS nurses case Engineers enter fight against AIDS in Africa Gilead’s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients UN chief Ban calls world leaders to end Aids by 2020 Tanzania: Police Abuse, Torture, Impede HIV Services Growing HIV/AIDS awareness in Indonesia's Papua region South Africa: Catastrophe as Eastern Cape drug stock-outs continue Community-led programmes critical to progress on AIDS in Sri Lanka One in Four Surveyed EU5 Physicians Has Been Required to Change a Prescription for Some or Most of Their HIV Patients in the Past Twelve Months, Primarily to Reduce Costs SOUTH CAROLINA: Lawsuit Filed over SC Tuberculosis Outbreak TAIWAN: HIV/AIDS Spreading to Younger People in Taiwan INDIA: WHO Issues Guide For New TB Drug TEXAS: Texas State Researchers Survey Students on HPV Awareness FLORIDA: Groups Offering Free HIV Testing TAIWAN: HIV/AIDS Spreading to Younger People in Taiwan FLORIDA: Groups Offering Free HIV Testing INDIA: HIV Prevention Among Female Sex Workers in India Reduces HIV and Syphilis Tanzania: Police Abuse, Torture, Impede HIV Services Growing HIV/AIDS awareness in Indonesia's Papua region US program marks birth of one millionth HIV-free baby One in Four Surveyed EU5 Physicians Has Been Required to Change a Prescription for Some or Most of Their HIV Patients in the Past Twelve Months, Primarily to Reduce Costs How long can one born with HIV live?Libya's "growing" drugs/HIV problem AHF: Porn Industry Says Condoms Limited Spread of Latest Adult Film HIV Infection
Information in this article was accurate in April 30, 1995. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.